Nisa Investment Advisors
AVIR icon

Nisa Investment Advisors’s Atea Pharmaceuticals AVIR Stock Holding History

Nisa Investment Advisors’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$493 Hold
106
– – ﹤0.01% 2949
2026
Q1 		$570 Hold
106
– – ﹤0.01% 2847
2025
Q4 		$378 Hold
106
– – ﹤0.01% 2851
2025
Q3 		$307 Hold
106
– – ﹤0.01% 2911
2025
Q2 		$382 Sell
106
-175
-62% -$522 ﹤0.01% 2909
2025
Q1 		$840 Buy
281
+258
+1,122% +$805 ﹤0.01% 2682
2024
Q4 		$77 Sell
23
-105
-82% -$349 ﹤0.01% 2990
2024
Q3 		$429 Sell
128
-54
-30% -$196 ﹤0.01% 2748
2024
Q2 		$602 Buy
182
+159
+691% +$593 ﹤0.01% 2645
2024
Q1 		$93 Hold
23
– – ﹤0.01% 2716
2023
Q4 		$70 Sell
23
-6,644
-100% -$20.1K ﹤0.01% 2624
2023
Q3 		$20K Buy
6,667
+1,220
+22% +$4.15K ﹤0.01% 2017
2023
Q2 		$20.4K Buy
+5,447
New +$20.4K ﹤0.01% 2098
2023
Q1 		– Sell
-120
Closed -$1K – 2529
2022
Q4 		$1K Buy
+120
New +$607 ﹤0.01% 2395

Other funds holding AVIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AI
Auour Investments Woburn, Massachusetts $349M AUM 13.68% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Nisa Investment Advisors's AVIR Position: Q2 2026 in Review

Nisa Investment Advisors held its Atea Pharmaceuticals (AVIR) position steady in Q2 2026 at 106 shares worth $493. The position accounts for ﹤0.01% of the portfolio, ranked #2949.

Nisa Investment Advisors first reported a position in AVIR in Q4 2022 and has held it in 14 quarters since. The position peaked at $20.4K in Q2 2023. 45 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • Nisa Investment Advisors held 106 shares of Atea Pharmaceuticals worth $493 as of Q2 2026.
  • Nisa Investment Advisors left its Atea Pharmaceuticals share count unchanged in Q2 2026.
  • Atea Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2949 holding.
  • Nisa Investment Advisors first reported a position in Atea Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
  • Nisa Investment Advisors's Atea Pharmaceuticals position peaked at $20.4K in Q2 2023.
  • 45 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.